Search

Your search keyword '"Otto C, Boerman"' showing total 520 results

Search Constraints

Start Over You searched for: Author "Otto C, Boerman" Remove constraint Author: "Otto C, Boerman"
520 results on '"Otto C, Boerman"'

Search Results

1. Multimodal CEA-targeted fluorescence and radioguided cytoreductive surgery for peritoneal metastases of colorectal origin

2. Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer

Catalog

Books, media, physical & digital resources

3. Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models

4. Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models

5. A pretargeted multimodal approach for image-guided resection in a xenograft model of colorectal cancer

6. Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy

7. Non-invasive in vivo determination of viable islet graft volume by 111In-exendin-3

8. Preclinical evaluation of PAC1 targeting with radiolabeled Maxadilan

9. Data from PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer

15. Supplementary Tables S1-S4 and Supplementary Figures S1-S12 from Digitalis-like Compounds Facilitate Non-Medullary Thyroid Cancer Redifferentiation through Intracellular Ca2+, FOS, and Autophagy-Dependent Pathways

17. Supplementary Figure 1 from Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

20. Data from Targeted Dual-Modality Imaging in Renal Cell Carcinoma: An Ex Vivo Kidney Perfusion Study

21. Data from Predicting IGF-1R Therapy Response in Bone Sarcomas: Immuno-SPECT Imaging with Radiolabeled R1507

22. Supplementary Figure 2 from Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

23. Data from Route of Administration Modulates the Induction of Dendritic Cell Vaccine–Induced Antigen-Specific T Cells in Advanced Melanoma Patients

25. Supplementary Table 2 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

26. Supplementary Figure 2 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

27. Supplementary Figure 1 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

28. Supplementary Table 1 from Natural Human Plasmacytoid Dendritic Cells Induce Antigen-Specific T-Cell Responses in Melanoma Patients

29. Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC

30. Imaging carbonic anhydrase IX as a method for monitoring hypoxia-related radioresistance in preclinical head and neck cancer models

31. Optimization of Dual-Labeled Antibodies for Targeted Intraoperative Imaging of Tumors

32. Upregulation of IGF-1R expression during neoadjuvant therapy predicts poor outcome in breast cancer patients.

33. Carcinoembryonic antigen-targeted photodynamic therapy in colorectal cancer models

34. Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with 111In-girentuximab

35. Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft Models

36. Pretargeted imaging and radioimmunotherapy of cancer using antibodies and bioorthogonal chemistry

37. Optimizing Lutetium 177–Anti–Carbonic Anhydrase IX Radioimmunotherapy in an Intraperitoneal Clear Cell Renal Cell Carcinoma Xenograft Model

38. Simlukafusp alfa (FAP-IL2v) immunocytokine is a versatile combination partner for cancer immunotherapy

39. 111In-exendin SPECT imaging suggests presence of residual beta cells in patients with longstanding type 1 diabetes

40. Pyruvate‐lactate exchange and glucose uptake in human prostate cancer cell models. A study in xenografts and suspensions by hyperpolarized [1‐13C]pyruvate MRS and [18F]FDG‐PET

41. Early follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with ¹¹¹In-girentuximab

42. Targeting of radioactive platinum-bisphosphonate anticancer drugs to bone of high metabolic activity

43. A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using Ga-68-RGD PET/CT

44. In Vitro and In Vivo Characterization of Three Ga- and In-Labeled Peptides for Cholecystokinin Receptor Imaging

45. F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography, Computed Tomography, and Magnetic Resonance Imaging for the Detection of Experimental Colorectal Liver Metastases

46. The kinetics and mechanism of bone morphogenetic protein 2 release from calcium phosphate-based implant-coatings

47. Digitalislike Compounds Restore hNIS Expression and Iodide Uptake Capacity in Anaplastic Thyroid Cancer

48. Preclinical Evaluation of Ga-DOTA-Minigastrin for the Detection of Cholecystokinin-2/Gastrin Receptor-Positive Tumors

49. Diannexin protects against renal ischemia reperfusion injury and targets phosphatidylserines in ischemic tissue.

50. Design of Radioiodinated Pharmaceuticals: Structural Features Affecting Metabolic Stability towards in Vivo Deiodination